Please assess the completion status of the following clinical trial:

Trial Title: Glyceryl Trinitrate Versus Lidocaine Cream for IUD Insertion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion criteria:~1. Women not taken analgesics or anxiolytics in the 24 hours prior insertion~2. Women not taken misoprostol prior to IUD insertion~3. No contraindication to or history of allergic reaction to lidocaine or NO donors.~4. Women who will accept to participate in the study~Exclusion criteria:~1. Lidocaine allergy~2. History of migraine or chronic headache~3. Any contraindication to IUD placement

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: f

Study Arms:
- glyceryl trinitrate cream (Type: EXPERIMENTAL): The clinician will perform a bimanual examination, place the speculum, and cleanse the cervix with Betadine. 1 mL glyceryl trinitrate cream will be placed on the cervix at the anterior lip and 1 mL in the cervix up to the level of the internal os using cotton swab.
- lidocaine cream (Type: EXPERIMENTAL): The clinician will perform a bimanual examination, place the speculum, and cleanse the cervix with Betadine. 1 mL lidocaine creamwill be placed on the cervix at the anterior lip and 1 mL in the cervix up to the level of the internal os using cotton swab.
- placebo cream (Type: PLACEBO_COMPARATOR): The clinician will perform a bimanual examination, place the speculum, and cleanse the cervix with Betadine.1 mL placebo cream will be placed on the cervix at the anterior lip and 1 mL in the cervix up to the level of the internal os using cotton swab.

Based on this trial design, predict the completion outcome and termination type (if applicable).